Joshua A. Kazam - Mar 7, 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: Director
Signature: /s/ Veer Bhavnagri, Attorney-in-Fact
Stock symbol: ALLO
Transactions as of: Mar 7, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/9/2022, 05:26 PM
Previous filing: Jan 14, 2022
Next filing: Jun 17, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLO	Common Stock	Other	$0	+413K	+159.38%	$0.00	672K	Mar 7, 2022	Direct	F1
transaction	ALLO	Common Stock	Gift	$0	-413K	-61.45%	$0.00	259K	Mar 7, 2022	Direct	F1

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this form did not involve a purchase or sale of securities by the reporting person. On March 7, 2022, the reporting person acquired securities previously held in trust for the benefit of the reporting person arising from the termination of the trust. On the same day, the reporting person transferred the same securities to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein.

Content

The transactions reported in this form did not involve a purchase or sale of securities by the reporting person. On March 7, 2022, the reporting person acquired securities previously held in trust for the benefit of the reporting person arising from the termination of the trust. On the same day, the reporting person transferred the same securities to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein.